The Alpha DaRT innovative alpha-radiation cancer therapy from Israel’s Alpha Tau (see here previously) has been used to treat a liver cancer patient in a Canadian clinical trial. The trial will include up to 10 patients with liver metastases (secondary cancer) from colorectal cancer.

https://www.ourcrowd.com/startup-news/alpha-tau-announces-alpha-dart-treatment-of-first-patient-with-liver-metastases-of-colorectal-cancer

https://clinicaltrials.gov/study/NCT05829291